Evome Medical Technologies Inc.
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Evome Medical Technologies Inc. (EVMT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of August 2024: -0.521x
Based on the latest financial reports, Evome Medical Technologies Inc. (EVMT) has a cash flow conversion efficiency ratio of -0.521x as of August 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$1.79 Million) by net assets (CA$-3.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evome Medical Technologies Inc. - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Evome Medical Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Evome Medical Technologies Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evome Medical Technologies Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TAKEDA PHARMA (TKD.SG)
STU:TKD
|
0.041x |
|
Siwani Makmur Tbk
JK:SIMA
|
3.493x |
|
Utron Ltd
TA:UTRN
|
0.127x |
|
Averbuch Formica Center Ltd
TA:AVER
|
0.047x |
|
Albaraka Turk Katilim Bankasi AS
IS:ALBRK
|
-0.403x |
|
Capitan Investment Ltd
V:CAI
|
0.042x |
|
Nate's Food Co
PINK:NHMD
|
0.147x |
|
Neste Corp
STU:NEF
|
0.001x |
Annual Cash Flow Conversion Efficiency for Evome Medical Technologies Inc. (2019–2023)
The table below shows the annual cash flow conversion efficiency of Evome Medical Technologies Inc. from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-11-30 | CA$4.00 Million | CA$-918.91K | -0.230x | +18.49% |
| 2021-11-30 | CA$13.15 Million | CA$-3.70 Million | -0.282x | +49.50% |
| 2020-11-30 | CA$6.64 Million | CA$-3.70 Million | -0.558x | -2580.02% |
| 2019-11-30 | CA$9.50 Million | CA$-197.61K | -0.021x | -- |